Portfolio Update

BLACKROCK GREATER EUROPE INVESTMENT TRUST plc All information is at 28 February 2014 and unaudited. Performance at month end with net income reinvested One Three One Three Since launch Month Months Year Years (20 Sep 04) Net asset value (undiluted) 5.9% 2.7% 13.6% 28.8% 204.3% Net asset value (diluted) 5.0% 2.3% 11.9% 30.0% 199.9% Share price 2.3% 3.3% 13.2% 33.4% 196.0% FTSE World Europe ex UK 5.4% 2.8% 15.4% 23.6% 137.3% Sources: BlackRock and Datastream At month end Net asset value (capital only): 255.70p Net asset value (including income): 255.80p Net asset value (capital only)*: 251.68p Net asset value (including income)*: 251.75p Share price: 247.50p Discount to NAV (including income): 3.2% Discount to NAV (including income)*: 1.7% Subscription share price 27.50p Gearing: 1.9% Net yield**: 1.8% Total assets (including income): £276.2m Ordinary shares in issue: 107,475,830*** Subscription shares in issue: 21,900,076 * Diluted for subscription shares and treasury shares. ** Based on an ordinary dividend of 4.5p per share (excluding a special dividend of 1.0p) for the year ended 31 August 2013. *** Excluding 5,529,676 shares held in treasury. Benchmark Sector Analysis Total Assets (%) Index (%) Country Analysis Total Assets (%) Financials 30.0 23.5 Switzerland 18.9 Health Care 16.3 12.1 France 17.8 Industrials 14.8 14.5 Germany 17.1 Consumer Goods 14.0 17.4 Netherlands 13.4 Consumer Services 12.5 5.3 Denmark 7.0 Technology 3.9 3.8 Sweden 6.1 Basic Materials 3.8 8.5 Belgium 4.2 Utilities 2.1 4.0 Russia 2.9 Oil & Gas 1.3 6.7 Turkey 2.7 Telecommunications - 4.2 Portugal 2.6 Net current assets 1.3 - Spain 2.4 ----- ----- Ireland 2.3 100.0 100.0 Hungary 1.0 ===== ===== Italy 0.3 Net current assets 1.3 ----- 100.0 ===== Ten Largest Equity Investments (in alphabetical order) Company Adecco Switzerland Bayer Germany Continental Germany Deutsche Post Germany ING Netherlands Novo Nordisk Denmark Publicis France Roche Switzerland Société Générale France Zurich Insurance Switzerland Commenting on the markets, Vincent Devlin, representing the Investment Manager noted: During the month, the Company's NAV gained 5.9% and the share price increased by 2.3%. For reference, the FTSE World Europe ex UK Index rose 5.4% during the same period. After a negative start to 2014, February saw a strong rally in European Equities, outperforming the rest of the world. This strong positive return came even as the European reporting season was generally uninspiring in terms of results, and despite generally conservative statements on 2014 outlooks. The Euro continued to appreciate. On a sector basis, health care led the way, followed by oil & gas and small and midcaps outperformed large caps during the month. February also saw the resurgence of some geopolitical risk following events in the Ukraine. Stock selection drove returns during the month, while sector allocation detracted from returns. From a sector perspective, the Company's underweight position to telecoms and an overweight position in health care benefited returns, although these were offset from an underweight position in oil & gas and an overweight position in consumer services. Stock selection within the health care and consumer goods sectors were the Company's largest contributors over the month. Within health care, a position in Danish diabetes treatment company, Novo Nordisk, was the Company's top performing stock. The company reported solid earnings and benefited from the news that a competitor's new rival drug has not demonstrated any improved efficiencies over its own product offering. A position in Roche also performed well as the product pipeline continues to build. Within the consumer goods sector, positions in French car manufacturer Renault and German tire and auto part manufacturer Continental performed strongly, as the European autos market strengthened and the demand for cars improved globally. On the negative side, stocks exposed to Emerging Europe suffered as the market continued to be dragged down. This was particularly noticeable in the Russian market as the situation in the Ukraine intensified. This led to Sberbank of Russia and Gazprom being the Company's two worst performing stocks. Other notable detractors were Hungarian OTP Bank, Turkish Halk Banka and Portuguese Jeronimo Martins, where the significant majority of its revenues are generated in Poland. At the end of the month, the Company was positioned with higher weightings in consumer services, financials and health care and with lower weightings in basic materials, oil & gas, industrials, utilities, consumer goods, technology and telecoms. Outlook The general outlook for Europe continues to improve, with growing evidence of a European economic recovery. Economic conditions are showing signs of improvement, public policy and political uncertainties have eased and the Eurozone has passed the peak of austerity measures. The fly in the ointment remains the ability of corporates to improve profits. However, lower labour and input costs combined with economic momentum, should provide the impetus much needed following a prolonged period of falling profits. We expect equity markets to provide a return of 10-12% this year given the potential for positive earnings surprise, valuation and dividend attractions and investors returning to European equities. However, it is worth reminding ourselves that there is risk surrounding any scenario. The recovery in Europe remains fragile and while much progress has been made in unifying the banking system, banking stress tests and lack of credit may hinder economic recovery. European elections could also bring some increased volatility but are unlikely to have a significant impact on future Eurozone policies. 13 March 2014 ENDS Latest information is available by typing www.brgeplc.co.uk on the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV terminal). Neither the contents of the Manager's website nor the contents of any website accessible from hyperlinks on the Manager's website (or any other website) is incorporated into, or forms part of, this announcement.
Investor Meets Company
UK 100